TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Euroform MediPharm AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
31,899
|
35,802
|
35,608 |
Financial expenses |
1
|
119
|
402 |
Earnings before taxes |
485
|
-3,530
|
-11,943 |
EBITDA |
1,091
|
-2,573
|
-4,611 |
Total assets |
24,143
|
24,763
|
27,589 |
Current assets |
21,389
|
21,484
|
23,436 |
Current liabilities |
9,481
|
9,400
|
11,783 |
Equity capital |
14,497
|
15,007
|
15,339 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
13
![]() |
13
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
60.0%
|
60.6%
|
55.6% |
Turnover per employee |
2,454
|
2,754
|
2,967 |
Profit as a percentage of turnover |
1.5%
|
-9.9%
|
-33.5% |
Return on assets (ROA) |
2.0%
|
-13.8%
|
-41.8% |
Current ratio |
225.6%
|
228.6%
|
198.9% |
Return on equity (ROE) |
3.3%
|
-23.5%
|
-77.9% |
Change turnover |
-3,903
|
194
|
6,538 |
Change turnover % |
-11%
|
1%
|
22% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
8%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.